Current through Register Vol. XLI, No. 50, December 13, 2024
Section 69-7-23 - Incident Reporting and Adverse Events23.1. Each opioid treatment program shall develop policies and procedures for comprehensively documenting, investigating, taking corrective action and tracking instances of adverse events or incidents.23.2. Adverse events or incidents are defined as an event which may involve: 23.2.a. Immediate threat to the care or safety of an individual, whether staff member, visitor or patient;23.2.b. The possibility of serious operational or personnel problems; or23.2.c. The potential to undermine public confidence in the treatment program.23.3. The adverse events or incidents may include:23.3.a. Agency medication errors;23.3.b. Potentially lethal patient suicide attempts23.3.d. Harm to family members or others from ingesting a patient's medication;23.3.e. Selling drugs on the premises;23.3.f. Medication diversion;23.3.g. Harassment or abuse of patients by staff; and23.4. Adverse events or incidents shall be reviewed on a quarterly basis by the advisory council which may choose to make recommendations to the administration or the governing body regarding improvements in the process to prevent further incidents.23.5. The program shall assure in the event of an adverse event or incident that: 23.5.a. The event or incident is fully documented and appropriately reported to the correct state agencies as necessary;23.5.b. There is prompt investigation and review of the situation surrounding the event or incident;23.5.c. Timely and appropriate corrective action is taken; and23.5.d. Ongoing monitoring of any corrective action takes place until effectiveness of the action is established.23.6. The opioid treatment program shall report any death involving drug overdose or drug-related complications to the state authority and the state oversight agency within forty-eight hours of the program receiving notification of the mortality.